Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Brazil

India's Ajanta Chooses Controversial Drug For First Product Launch

November 2007 | Company News Alert
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

India's Ajanta Pharma has made its first foray into Brazil's drug market through a partnership with Canada's Cobalt Pharmaceuticals, part of the Arrow Group. Ajanta's first product will be the prescription analgesic nimesulide. The company hopes to expand to market a range of 10-12 products by the end of